Tesamorelin is a growth hormone-releasing factor (GHRH) analogue peptide designed specifically to target deep abdominal fat accumulation. In today’s biohacking and physical performance landscape, this compound stands out for its unique ability to induce selective lipolysis in the body’s most resistant visceral fat zones.
Unlike conventional fat burners that merely reduce water weight or general subcutaneous fat, Tesamorelin acts directly by stimulating the endogenous synthesis and pulsatile release of Human Growth Hormone (HGH). This triggers a metabolic cascade that targets visceral fat—the metabolically harmful fat surrounding internal organs—while simultaneously promoting a drastic improvement in muscle definition, nutrient partitioning, and the researcher’s overall metabolic profile.